Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo
Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Candida albicans
is a fungal pathogen that is difficult to cure clinically. The current clinic
C. albicans
-inhibiting drugs are very harmful to humans. This study revealed the potential of iturin fractions from
Bacillus subtilis
to inhibit
C. albicans
in free status (MIC = 32 μg/mL) and natural biofilm in vitro. The inhibition...
Alternative Titles
Full title
Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2211326618
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2211326618
Other Identifiers
ISSN
0175-7598
E-ISSN
1432-0614
DOI
10.1007/s00253-019-09805-z
